Sustained plasma TNF-alpha and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans
- PMID: 10563708
- DOI: 10.1097/00002030-199911120-00005
Sustained plasma TNF-alpha and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans
Abstract
Objective: To determine the impact of treatment of tuberculosis on plasma HIV-1 load in African subjects and to correlate viral load with response to treatment and changes in immune activation.
Design: Clinical and microbiological responses, immune activation parameters and plasma HIV-1 load were determined in 20 patients with pulmonary tuberculosis and HIV-1 coinfection in Ghana, West Africa during the first 3 months of anti-tuberculosis treatment.
Methods: Plasma HIV-1 load and markers of immune activation were determined by commercially available assays. Human leukocyte antigen (HLA)-DR incorporation into the HIV-1 envelope was measured by using an immunomagnetic capture technique.
Results: Treatment of tuberculosis resulted in significant improvements in weight and haemoglobin, a high sputum smear conversion rate and marked reductions in mean plasma tumour necrosis factor (TNF) receptor-1, interleukin-6 and C-reactive protein. Furthermore, incorporation of host HLA-DR into the HIV-1 envelope decreased; this also suggested a reduction in immune activation of the cells supporting viral replication. However, of importance with regard to AIDS pathogenesis, neither mean plasma TNF-alpha nor HIV-1 load decreased significantly.
Conclusions: The failure of HIV-1 plasma load to decline significantly during the initial months of anti-tuberculosis treatment is associated with high, sustained systemic levels of TNF-alpha. The dissociation between the sustained levels of plasma TNF-alpha and the major reductions in other, diverse immune activation parameters may represent dysregulation of cytokine production in these African patients.
Similar articles
-
Changes in HIV RNA viral load, CD4+ T-cell counts, and levels of immune activation markers associated with anti-tuberculosis therapy and cotrimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan, Cote d'Ivoire.J Med Virol. 2005 Feb;75(2):202-8. doi: 10.1002/jmv.20257. J Med Virol. 2005. PMID: 15602734
-
Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients.J Infect Dis. 2003 Jun 15;187(12):1967-71. doi: 10.1086/375346. Epub 2003 Jun 4. J Infect Dis. 2003. PMID: 12792875 Clinical Trial.
-
Dynamics of plasma cytokine levels in patients with advanced HIV infection and active tuberculosis: implications for early recognition of patients with poor response to anti-tuberculosis treatment.AIDS. 1999 May 28;13(8):935-41. doi: 10.1097/00002030-199905280-00009. AIDS. 1999. PMID: 10371174
-
Diagnosis and management of tuberculosis in patients with HIV infection.Mt Sinai J Med. 1998 Jan;65(1):14-21. Mt Sinai J Med. 1998. PMID: 9458679 Review. No abstract available.
-
Influence of microbial infections on the progression of HIV disease.Trends Microbiol. 1997 Aug;5(8):326-31. doi: 10.1016/S0966-842X(97)01089-5. Trends Microbiol. 1997. PMID: 9263412 Review.
Cited by
-
Impact of HIV co-infection on plasma level of cytokines and chemokines of pulmonary tuberculosis patients.BMC Infect Dis. 2014 Mar 4;14:125. doi: 10.1186/1471-2334-14-125. BMC Infect Dis. 2014. PMID: 24592945 Free PMC article.
-
HIV and co-infections.Immunol Rev. 2013 Jul;254(1):114-42. doi: 10.1111/imr.12063. Immunol Rev. 2013. PMID: 23772618 Free PMC article. Review.
-
Immune recovery after starting ART in HIV-infected patients presenting and not presenting with tuberculosis in South Africa.J Acquir Immune Defic Syndr. 2013 May 1;63(1):142-5. doi: 10.1097/QAI.0b013e318288b39d. J Acquir Immune Defic Syndr. 2013. PMID: 23364513 Free PMC article.
-
Predictors of change in nutritional and hemoglobin status among adults treated for tuberculosis in Tanzania.Int J Tuberc Lung Dis. 2011 Oct;15(10):1380-9. doi: 10.5588/ijtld.10.0784. Int J Tuberc Lung Dis. 2011. PMID: 22283899 Free PMC article.
-
Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3.J Infect Dis. 2011 Apr 1;203(7):992-1001. doi: 10.1093/infdis/jiq141. J Infect Dis. 2011. PMID: 21402550 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials